ES2149969T3 - Composicion antitusiva que contiene un antitusivo y benzidamina. - Google Patents

Composicion antitusiva que contiene un antitusivo y benzidamina.

Info

Publication number
ES2149969T3
ES2149969T3 ES95909772T ES95909772T ES2149969T3 ES 2149969 T3 ES2149969 T3 ES 2149969T3 ES 95909772 T ES95909772 T ES 95909772T ES 95909772 T ES95909772 T ES 95909772T ES 2149969 T3 ES2149969 T3 ES 2149969T3
Authority
ES
Spain
Prior art keywords
antitusive
benzidamine
composition containing
oral
acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95909772T
Other languages
English (en)
Inventor
Angeli Depalmo Galli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2149969T3 publication Critical patent/ES2149969T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA ANTITUSIVA ORAL QUE PERMITE UN CONTACTO SIGNIFICATIVO DE SUS COMPONENTES CON LAS MEMBRANAS MUCOSAS DE LA CAVIDAD BUCAL Y ESTA COMPUESTO POR UN ANTITUSIVO DE ACCION CENTRAL O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES Y BENZIDAMINA O UNA DE SUS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE.
ES95909772T 1994-03-01 1995-02-22 Composicion antitusiva que contiene un antitusivo y benzidamina. Expired - Lifetime ES2149969T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940362A IT1274026B (it) 1994-03-01 1994-03-01 Composizione antitosse

Publications (1)

Publication Number Publication Date
ES2149969T3 true ES2149969T3 (es) 2000-11-16

Family

ID=11368015

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95909772T Expired - Lifetime ES2149969T3 (es) 1994-03-01 1995-02-22 Composicion antitusiva que contiene un antitusivo y benzidamina.

Country Status (27)

Country Link
US (1) US5932589A (es)
EP (1) EP0748222B1 (es)
JP (1) JP3348858B2 (es)
KR (1) KR970701047A (es)
CN (1) CN1088358C (es)
AT (1) ATE195074T1 (es)
AU (1) AU681257B2 (es)
BR (1) BR9506956A (es)
CA (1) CA2184594C (es)
CZ (1) CZ284798B6 (es)
DE (1) DE69518229T2 (es)
DK (1) DK0748222T3 (es)
ES (1) ES2149969T3 (es)
FI (1) FI963394A (es)
GR (1) GR3034665T3 (es)
HU (1) HUT75937A (es)
IT (1) IT1274026B (es)
NO (1) NO309965B1 (es)
NZ (1) NZ281230A (es)
PL (1) PL178608B1 (es)
PT (1) PT748222E (es)
RO (1) RO117147B1 (es)
RU (1) RU2143901C1 (es)
SK (1) SK282567B6 (es)
UA (1) UA37278C2 (es)
WO (1) WO1995023602A1 (es)
ZA (1) ZA951588B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124282A (en) * 1997-05-22 2000-09-26 Sellers; Edward M. Drug formulations
CA2314893C (en) * 1997-12-22 2005-09-13 Euro-Celtique, S.A. Opioid agonist/antagonist combinations
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
PL1848403T3 (pl) * 2005-01-14 2010-09-30 Camurus Ab Preparaty bioadhezyjne o działaniu miejscowym
SI1845942T1 (sl) * 2005-01-14 2014-06-30 Camurus Ab Gnrh analogne formulacije
CN101219140B (zh) * 2007-12-24 2011-06-01 重庆市莱美药物技术有限公司 盐酸苄达明可溶片及其制备方法
SI2451452T1 (sl) 2009-07-08 2015-12-31 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. Uporaba benzidamina pri zdravljenju bolezni, odvisnih od p40
CA2904045C (en) * 2013-03-13 2022-03-29 Tris Pharma, Inc. Benzonatate modified release solid tablets and capsules
CA2976187A1 (en) * 2015-02-09 2016-08-18 Cellix Bio Private Limited Benzydamine salts and compositions thereof useful for the treatment of mucositis
US11214544B2 (en) 2017-04-14 2022-01-04 Kempharm, Inc. Dextrorphan prodrugs and processes for making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
EP0555411A1 (en) * 1990-10-31 1993-08-18 The Procter & Gamble Company Dextromethorphan antitussive compositions

Also Published As

Publication number Publication date
EP0748222A1 (en) 1996-12-18
KR970701047A (ko) 1997-03-17
FI963394A0 (fi) 1996-08-30
BR9506956A (pt) 1997-09-16
CN1088358C (zh) 2002-07-31
PT748222E (pt) 2001-01-31
RO117147B1 (ro) 2001-11-30
CA2184594A1 (en) 1995-09-08
PL178608B1 (pl) 2000-05-31
ATE195074T1 (de) 2000-08-15
US5932589A (en) 1999-08-03
UA37278C2 (uk) 2001-05-15
GR3034665T3 (en) 2001-01-31
IT1274026B (it) 1997-07-14
NZ281230A (en) 1998-04-27
CZ284798B6 (cs) 1999-03-17
ZA951588B (en) 1995-12-08
RU2143901C1 (ru) 2000-01-10
CA2184594C (en) 2002-09-17
NO963634L (no) 1996-08-30
JP3348858B2 (ja) 2002-11-20
MX9603747A (es) 1997-12-31
WO1995023602A1 (en) 1995-09-08
ITMI940362A1 (it) 1995-09-01
PL316079A1 (en) 1996-12-23
AU1811695A (en) 1995-09-18
CN1143909A (zh) 1997-02-26
CZ253296A3 (en) 1997-01-15
NO963634D0 (no) 1996-08-30
DK0748222T3 (da) 2000-12-18
DE69518229T2 (de) 2001-03-08
HU9602390D0 (en) 1996-10-28
FI963394A (fi) 1996-08-30
SK282567B6 (sk) 2002-10-08
ITMI940362A0 (it) 1994-03-01
NO309965B1 (no) 2001-04-30
SK108596A3 (en) 1997-04-09
EP0748222B1 (en) 2000-08-02
JPH09509670A (ja) 1997-09-30
DE69518229D1 (de) 2000-09-07
HUT75937A (en) 1997-05-28
AU681257B2 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
ES2149969T3 (es) Composicion antitusiva que contiene un antitusivo y benzidamina.
ES2154288T3 (es) Composicion farmaceutica bioadhesiva para la liberacion controlada de principios activos.
AR002932A1 (es) Solucion acuosa de interferon
ES2059446T3 (es) Composicion de copolimero bloque hidrogenado especifico y procedimiento para su fabricacion.
TR199901077A2 (en) �spen�iyari form�lasyonlar.
ES2099056T1 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
DE3865553D1 (de) Elektrodenlose niederdruckentladungslampe.
ES2166813T3 (es) Composicion limpiadora para dentaduras.
DE3854187D1 (de) Hochdruckentladungslampe.
DE3865757D1 (de) Elektrodenlose niederdruckentladungslampe.
PT1131408E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
DE69608959D1 (de) Chlamydia impfstoffen
ES2109632T3 (es) Composicion de dentifrico anhidro.
PA7801701A1 (es) Compuestos ariltios
DE3888808D1 (de) Hochdruckentladungslampe.
FI945609A0 (fi) Makromonomeereja sisältävät vesipitoiset lateksit
IT8621291A0 (it) Composizioni per la disinfezione di lenti a contatto.
ITMI922314A1 (it) Metodo per la disinfezione delle lenti a contatto
IT8922281A0 (it) Composizioni e metodo per la disinfezione e la pulizia delle lenti a contatto rigide, semirigide e morbide.
IT8720770A0 (it) Metodo per la disinfezione, pulizia e detersione delle lenti a contatto e confezione relativa.
IT1272995B (it) Procedimento migliorato per la preparazione della 14b-idrossi-etianaldeide.
SU1528196A1 (ru) Материал для светозвукопроводов акустооптических синхронизаторов мод лазеров
IT8420745A0 (it) Composizione solida e metodo per la disinfezione di lenti a contatto.
ITRM910200A1 (it) Procedimento per la produzione di lenti oftalmiche a contatto.
GR1001368B (el) Φαρμακευτικοί φορείς.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 748222

Country of ref document: ES